Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.71
-0.19 (-1.37%)
At close: Jun 23, 2026, 4:00 PM EDT
13.29
-0.42 (-3.06%)
Pre-market: Jun 24, 2026, 4:11 AM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $197.73 million as of June 24, 2026. Its market cap has increased by 44.32% in one year.
Market Cap
197.73M
Enterprise Value
83.57M
1-Year Change
44.32%
Ranking
Category
Stock Price
$13.71
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $197.73M, an increase of 59.72%. That is a compound annual growth rate of 19.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 197.73M | 162.13% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 207.27M |
| Galectin Therapeutics | 205.47M |
| Outlook Therapeutics | 205.47M |
| Immunic | 205.28M |
| Alector | 203.18M |
| Minerva Neurosciences | 202.66M |
| Q32 Bio | 201.44M |
| Arcturus Therapeutics Holdings | 201.24M |